Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Nitinol has superelastic properties that allow medical devices using it to compress to a lower profile when placed in a ...

"The Capstan technology exceeded our expectations even in these early cases." Heart disease remains the leading cause of death in the world, claiming a life every 33 seconds in the U.S. alone.

Elsewhere in the arterial graft space, Capstan Medical has raised $110m to advance its robotic platform for cardiac disease treatment for patients living with heart failure. Meanwhile, Endospan ...

Capstan, which has operations in San Diego and ... network of more than 500 outpatient care sites and medical school. “Leading Penn Medicine at such a critical time in the evolution of medicine ...